Technology Networks

Genta Corporation

Two Connell Drive,
Berkeley Heights,
NJ 07922
United States of America
Tel: (908) 286-9800
Fax:

Print Email to a friend

Genta Incorporated is a biopharmaceutical company focused on the identification, development and commercialization of drugs for the treatment of patients with cancer. Our rich pipeline is anchored by 2 key components: DNA Medicines franchise (which include products that employ Antisense and Decoy technology); and our Small Molecule programs (including Gallium Products and Androgenics).

Further Information: http://www.genta.com



Related news from our archive

Genta to Support Initiation of New Clinical Trial using Ganite®
Company will supply Ganite® for a new clinical trial as treatment for life-threatening infections in patients with cystic fibrosis.

Genasense® Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma
Results follow decision by company to continue Phase 3 AGENDA trial for overall survival.

Genta Initiates new Clinical Trial of Tesetaxel, the Leading Oral Taxane in Clinical Development
The new study will examine the clinical pharmacology of the drug over a narrow dosing range around the established Phase 2 dose.